Skip to content
Rameda Pharma
Rameda Pharma
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact
Corporate Website
  • ع
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact

Portfolio Archive:

You are here:
  1. Home
  2. Project
Details

BOD Meeting Minutes on 14 December 2022

Board and Shareholders ActionsBy adminDecember 14, 2022
Details

ESG 3Q22 Presentation

ESG PresentationsBy adminNovember 30, 2022
Details

9M2022 Investor Presentation

By adminNovember 16, 2022
Details

Consolidated financial statements for the period ended 30 September 2022

Consolidated Financial Statements resultsBy adminNovember 15, 2022
Details

Rameda 3Q22 Earnings Release

Earings ReleasesBy adminNovember 15, 2022
Details

Board of Directors Report on 14 November 2022

Board and Shareholders ActionsBy adminNovember 15, 2022
Details

Standalone financial statements for the period ended 30 September 2022

Standalone Financial StatementsBy adminNovember 15, 2022
Details

BOD Meeting Minutes on 14 November 2022

Board and Shareholders ActionsBy adminNovember 14, 2022
Details

Summary of OGM Resolutions

Board and Shareholders ActionsBy adminSeptember 29, 2022
Details

BOD Meeting Minutes on 4 September 2022

Board and Shareholders ActionsBy adminSeptember 5, 2022
←1
234
…56789…
10111213141516
17→

All Rights Reserved © 2024

Go to Top